Page URL:

Early trial of epigenetic blood test for post-natal depression

28 May 2013
Appeared in BioNews 706

A blood test that looks for chemical alterations to certain genes may help predict whether pregnant women will develop post-natal depression, scientists say after a small study.

Researchers analysed blood samples from 51 women, all with a history of mood disorders, who were followed during and after pregnancy. From a sub-group of 32 women without symptoms of depression during their third trimester, 11 became depressed within four weeks of giving birth. Twelve women from a sub-group of 19 who were depressed during pregnancy remained so after birth. Chemical alterations, known as 'epigenetic changes', to two genes were closely associated with the development of post-natal depression.

'We were pretty surprised by how well the genes were correlated with post-natal depression', said Dr Zachary Kaminsky, assistant professor of psychiatry and behavioural sciences at Johns Hopkins University School of Medicine, USA, and senior author of the study.

Levels of the hormone oestrogen drop following childbirth. Dr Kaminsky's team suspected that this could prompt epigenetic changes to genes that are important in the hippocampus, a part of the brain that helps regulate mood. These epigenetic changes alter the way genes function without interfering with the genetic sequence.

The researchers began by studying one epigenetic mechanism, DNA methylation, in the hippocampus of mice. Statistical models identified two genes – HP1BP3 and TTC9B – that looked likely to be involved in post-natal depression.

The clinical study gave early confirmation of this. Women who developed post-natal depression showed higher levels of DNA methylation to the two identified genes. However, one potentially confounding variable in the study was that all the women had histories of depression or bipolar disorder.

Next, the researchers hope to follow a larger sample of women for longer. Ultimately the team hopes to develop a blood test predicting a woman's risk of post-natal depression.

'If you knew you were likely to develop postpartum depression, your decisions about managing your care could be made more clearly', Dr Kaminsky commented.

In the UK, approximately one woman in seven develops depression after having a baby. NHS Choices notes that the persistent low mood 'usually develops in the first four to six weeks after childbirth, although in some cases it may not develop for several months'.

Antenatal prediction of postpartum depression with blood DNA methylation biomarkers
Molecular Psychiatry |  21 May 2013
Epigenetic Changes Predict Postpartum Depression
Genetic Engineering and Biotechnology News |  21 May 2013
Genetic Predictors of Postpartum Depression Uncovered by Johns Hopkins Researchers
Johns Hopkins Medicine (press release) |  21 May 2013
New blood test could predict post-natal depression
Daily Telegraph |  22 May 2013
The blood test that can identify women most at risk of post-natal depression
Mail Online |  22 May 2013
3 August 2015 - by Dr Linda Wijlaars 
Epigenetic variation can predict the risk of post-natal depression symptoms in women without a history of depression, researchers from the UK and US have found...
8 July 2013 - by Dr Linda Wijlaars 
Two genetic variants that are involved in the stress response have been linked to postnatal depression.
20 May 2013 - by Dr Amina Aitsi-Selmi 
Genes believed to regulate sleep rhythm are expressed abnormally in people with major depressive disorders, scientists say...
4 March 2013 - by Dr Anna Cauldwell 
Five of the most common psychiatric disorders share genetic risk factors, an international study published in the Lancet has found...
3 December 2012 - by Maren Urner 
The risk of depression in adolescents exposed to negative environments during their childhood is partly dependent on their genetic make-up, suggest researchers...
26 November 2012 - by Dr Nicola Davis 
A gene linked to obesity may also provide protection from major depression, say scientists...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.